HIGHLIGHTS: Thomas Schinecker - CEO of Roche
In Good Company with Nicolai Tangen
Intro
This chapter explores the historical evolution of the pharmaceutical industry in Basel, Switzerland, emphasizing its significance as a biopharma hub. It highlights key advancements in cancer treatment, including genome sequencing and the future potential of personalized cancer vaccines.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
